Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. - Wikidata - awgldk - TriplyDB

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.

http://www.wikidata.org/entity/Q40612368

about

EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?Epidermal growth factor receptor structural alterations in gastric cancer A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.Molecular biology of gastric carcinoma: from laboratory to bedside.Tyrosine kinases and gastric cancer.Molecular targeting to treat gastric cancer.Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer.HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain.Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma Functional epidermal growth factor gene polymorphisms and risk of gastric cancer.Gastrin - active participant or bystander in gastric carcinogenesis?Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.EGFR regulates macrophage activation and function in bacterial infection.CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract ERBBs in the gastrointestinal tract: recent progress and new perspectives.Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer.Novel investigational drugs for gastric cancer.Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study.Anti-HER agents in gastric cancer: from bench to bedside.How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer.Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity.Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.HER2 as a therapeutic target in the gastric cancer: is it sufficient?Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases.Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system.Rapid decrease in salivary epidermal growth factor levels in patients with Sjögren's syndrome: A 3-year follow-up study.

P2860

Q28538710-23CE65D1-3C5F-4698-8071-CC43D501D7BC Q33315034-B1517096-040C-4104-9AC1-1F11A0FA186A Q33387432-469FCBA8-D35F-431E-8C9B-8E97F12FEE24 Q33746885-8B18003A-D618-44E6-8182-0575B673F3BE Q33816796-4F07BD26-5B6D-4134-99B9-EE98BBF2536A Q34103663-ED61FF5F-7555-4BF7-AFA1-267FD8A95205 Q34326593-81A9C514-D8C2-4E3A-9574-06D84470FE59 Q34521412-876F45D1-1DF2-49C3-8BF6-8C6E6F6AA81E Q34855628-2C9CEDC1-FFAF-4567-8FD0-E36F2C56ED98 Q35495307-7A739991-0C24-4075-B485-4254B4592060 Q35565614-B56722E8-CDC0-4363-A744-64E330F3FB0F Q35569862-AECF1743-5D75-4789-A326-CB8359459786 Q35963767-FA7C6A19-CB5C-4971-9320-B6076AF559D1 Q36216766-0B7C073E-FAED-4000-B691-B7060C08B6F9 Q36341670-7D46EC8D-DE04-48F6-9942-60468B4F3DD7 Q36383409-0B70B15D-67AF-44D5-A4EA-1646B8F18D12 Q36611689-71BF6A0F-8E60-4695-9028-9D97421C6947 Q36664970-FF790670-D432-409B-B71D-520E700FAE39 Q37041198-2C50E792-1F52-4222-B8CF-68E3B1E3CA3E Q37062357-3385D199-A195-4939-9A37-AD45540DC406 Q37217464-91A357F7-F6AD-4873-B3AC-F21221AA2BCC Q37234000-23C08B09-FFD8-43C6-BC85-777B0D128DCF Q37337542-FB689DAE-4971-49AA-B0A8-DC79F9F0C614 Q37398646-FD3B8798-9FCA-4E81-9072-0C1EAE179BCB Q37401491-98F8F993-1E8F-4BCF-86F3-E192FAA2168A Q37446964-35EC465F-57F5-41AF-9525-6B4424FE5FCC Q37494644-7711A9C0-5A55-4FB8-8D6F-3E457F2812BD Q37522211-179B6013-5369-45F1-A0E9-06D25B64708D Q37885725-C9DEBA58-5F08-4391-AF12-CB0A5C02119E Q38241766-EAC5A02C-418D-4816-AE7D-C037B9FEF886 Q38504936-18045410-D609-4774-934C-4D78BB8E6D40 Q38926824-448931F5-21C7-40DB-AB18-B5D857B3D84E Q39990738-D354FE70-888D-4B2D-BAD0-6A0D9F19B30F Q40260379-13826CA4-562D-440E-8AB7-4DA07A53FC9E Q40592991-B5D4EEB9-536A-4313-AAED-EBD776CE5CBC Q41971798-B23EF93E-ED1C-41F7-902B-8651F560E6F6 Q42846225-10F7C7DA-FE0B-4163-9E4D-5209E1D6CF06 Q43202355-B6B32624-22D8-4078-B2CB-86D4B90CA889 Q47791804-3B2F1730-BF90-442B-939C-3CCF31B540EA Q48041483-0AEF0078-502E-4396-B473-159EA5E40142

P2860

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.

http://www.wikidata.org/entity/Q40612368

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Clinical significance of epide ...... rbB-2 in human gastric cancer.

@en

type

label

Clinical significance of epide ...... rbB-2 in human gastric cancer.

@en

prefLabel

Clinical significance of epide ...... rbB-2 in human gastric cancer.

@en

P1433

Q40612368-E90E0CC2-F9F2-410C-B088-41527D3D85CC

P1476

Q40612368-2701EE52-170B-4683-9AFC-67C9274A6E55

P2093

Q40612368-0649688E-CD2F-470F-AECA-918FDB2D501C

Q40612368-248AF0C1-AAAE-4B6F-A62E-CFB52C56157E

Q40612368-397240F5-FE09-417B-BAF2-F41DED6777AB

Q40612368-5DBC9730-3141-495C-996F-FB44F482556D

Q40612368-5E142EC7-A6E0-4EA6-BF43-6E74534526D0

Q40612368-99DE5F93-C2B1-4D98-80CA-D46751EAB104

Q40612368-9AB3D74B-62A4-4652-9CBC-DA98E31A145A

Q40612368-B3D2370A-2D16-40CF-B80F-0066C99F41FE

Q40612368-DC555D00-B1FB-4FF7-A034-6B9B534C08D4

Q40612368-E72834DC-B091-42C3-ABA2-BBDE8E10AB8F

P2860

Q40612368-1938AB89-6AA6-4316-A32C-834853245B83

Q40612368-224EC011-E144-4E8C-8B29-EF2ABD033144

Q40612368-57D5D43D-1FB8-46B3-AFB3-F7D4B321F4CB

Q40612368-60BE3ADE-5FA9-4A03-9D64-FCA9EC82B312

Q40612368-725CA2A8-318A-4257-B7A3-F6B55FFB6E9A

Q40612368-B443DFAE-4BA9-4957-B7CE-3CB474762177

Q40612368-BC847142-5E68-47F8-8AA7-5B79208C1C22

Q40612368-BF27014C-F6D3-477E-A136-8230458645E3

Q40612368-C88E23DA-8FC4-461B-AF61-7DED77A62214

Q40612368-CFA970EA-ECD2-489C-869E-85996FDA8F67

P304

Q40612368-7FE517C9-E4C9-4C51-BF15-C552CBC76C7B

P31

Q40612368-FFD62AEB-0B80-4082-9D78-EA6F7760CCC2

P356

Q40612368-5C34EF76-26AC-4860-A8B8-9897402C60EE

P407

Q40612368-13332145-4003-4A5E-81A3-B97DA689A689

P433

Q40612368-D4C8CEDB-3996-43B0-954E-2E62222B2706

P478

Q40612368-DB318CBB-EF45-428B-A066-620D62AD4F05

P577

Q40612368-6F91E0FF-6567-4DD5-8A60-F10642801804

P698

Q40612368-47C7D2EB-A4DE-4DCE-A6BA-4780DB2AD636

P356

1097-0142(19950315)75:6%2B%3C1418::AID-CNCR2820751505%3E3.0.CO;2-Y

P1433

P1476

Clinical significance of epide ...... rbB-2 in human gastric cancer.

@en

P2093

Fujita I

http://www.w3.org/2001/XMLSchema#string

Kiyama T

http://www.w3.org/2001/XMLSchema#string

Matsukura N

http://www.w3.org/2001/XMLSchema#string

Mizutani T

http://www.w3.org/2001/XMLSchema#string

Nishi K

http://www.w3.org/2001/XMLSchema#string

Okuda T

http://www.w3.org/2001/XMLSchema#string

Onda M

http://www.w3.org/2001/XMLSchema#string

Teramoto T

http://www.w3.org/2001/XMLSchema#string

Tokunaga A

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki T

http://www.w3.org/2001/XMLSchema#string

P2860

The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity

Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa.

Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.

BE-23372M, a novel and specific inhibitor for epidermal growth factor receptor kinase.

Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas.

Alterations of oncogenes in metastatic tumours of human gastric carcinomas

Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach.

Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta.

Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1.

Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.

P304

1418-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0142(19950315)75:6+<1418::AID-CNCR2820751505>3.0.CO;2-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

6 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1995-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7889468

http://www.w3.org/2001/XMLSchema#string